John W. Beck

Plus aucun poste en cours

Profil

John W.
Beck founded Metabasis Therapeutics, Inc. in 1998, where he worked as Chief Financial Officer, Treasurer & Senior VP from 1998 to 2008.
Mr. Beck also formerly worked at Neurocrine Biosciences, Inc., as Finance Director from 1994 to 1998, Artelo Biosciences, Inc., as Independent Director from 2019 to 2021, August Therapeutics, Inc., as Director, Pinnacle Medical Holdings, LLC, as Director, Clinicon Corp., as Director, Ritter Pharmaceuticals, Inc., as Chief Financial Officer from 2018 to 2020, The American Institute of Certified Public Accountants, as Member, Financial Executives International, as Member, Ardea Biosciences, Inc., as Chief Financial Officer & Senior VP-Operations from 2011 to 2012, The Association of Bioscience Financial Officers, as Member, and 4D Pharma Plc, as Chief Financial Officer in 2021.
Mr. Beck received his undergraduate degree from the University of Washington.

Anciens postes connus de John W. Beck

Sociétés	Poste	Fin
The Association of Bioscience Financial Officers	Corporate Officer/Principal	26/07/2021
The American Institute of Certified Public Accountants	Corporate Officer/Principal	26/07/2021
Financial Executives International	Corporate Officer/Principal	26/07/2021
Clinicon Corp.	Directeur/Membre du Conseil	26/07/2021
ARTELO BIOSCIENCES, INC.	Directeur/Membre du Conseil	20/07/2021